Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells

Dimitrios N. Vatakis, Richard C. Koya, Christopher C. Nixon, Liu Wei, Sohn G. Kim, Patricia Avancena, Gregory Bristol, David Baltimore, Donald B. Kohn, Antoni Ribas, Caius G. Radu, Zoran Galic, Jerome A. Zack